C
LFCR icon

Covestor’s Lifecore Biomedical LFCR Stock Holding History

Covestor’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44K Hold
8,313
– – 0.03% 862
2026
Q1 		$31K Sell
8,313
-34
-0.4% -$235 0.02% 940
2025
Q4 		$68K Buy
8,347
+944
+13% +$6.98K 0.04% 777
2025
Q3 		$54K Sell
7,403
-8
-0.1% -$61 0.03% 871
2025
Q2 		$60K Buy
7,411
+569
+8% +$3.84K 0.04% 822
2025
Q1 		$48K Hold
6,842
– – 0.03% 864
2024
Q4 		$51K Hold
6,842
– – 0.03% 852
2024
Q3 		$34K Buy
6,842
+273
+4% +$1.43K 0.02% 1018
2024
Q2 		$34K Buy
6,569
+2,786
+74% +$16.5K 0.02% 1007
2024
Q1 		$20K Sell
3,783
-2,960
-44% -$21.2K 0.01% 1217
2023
Q4 		$41K Sell
6,743
-534
-7% -$3.71K 0.03% 938
2023
Q3 		$55K Buy
7,277
+42
+0.6% +$384 0.04% 731
2023
Q2 		$70K Buy
7,235
+4,396
+155% +$26.8K 0.05% 634
2023
Q1 		$11K Buy
+2,839
New +$15.8K 0.01% 1270

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Covestor's LFCR Position: Q2 2026 in Review

Covestor held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 8,313 shares worth $44K. The position accounts for 0.03% of the portfolio, ranked #862.

Covestor first reported a position in LFCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $70K in Q2 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Covestor held 8,313 shares of Lifecore Biomedical worth $44K as of Q2 2026.
  • Covestor left its Lifecore Biomedical share count unchanged in Q2 2026.
  • Lifecore Biomedical made up 0.03% of Covestor's portfolio in Q2 2026, its #862 holding.
  • Covestor first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 14 quarters since.
  • Covestor's Lifecore Biomedical position peaked at $70K in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.